Effect of agmatine on spinal nociceptive reflexes: Lack of interaction with α2-adrenoceptor or μ-opioid receptor mechanisms

European Journal of Pharmacology

Volumn 331, Issue 2-3, 1997, Pages 133-138

  Bradley, Kate J ^a   Headley, P Max ^a  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

2 Adrenoceptor; Opioid receptor; Agmatine; Analgesia; Fentanyl; Spinal cord

Indexed keywords

AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; ATIPAMEZOLE; FENTANYL; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SPINAL CORD;

ADRENERGIC ALPHA-ANTAGONISTS; AGMATINE; ANALGESICS, OPIOID; ANIMALS; BLOOD PRESSURE; ELECTRIC STIMULATION; FENTANYL; HINDLIMB; MALE; MOTOR NEURONS; MUSCLE, SKELETAL; NOCICEPTORS; PHYSICAL STIMULATION; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID, MU; REFLEX; SPINAL CORD;

EID: 0030859966     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01043-1     Document Type: Article

References (28)

1. Bradley, K.J., Headley, P.M., 1996. Effect of agmatine on spinal nociceptive responses in anaesthetised rats. J. Physiol. 495, 27P.
2. Das, I., Khan, N.S., 1995. Inhibition of nitric oxide synthase by L-arginine metabolites. Biochem. Soc. Trans. 23, 324S.
3. Duggan, A.W., Griersmith, B.T., Headley, P.M., Maher, J.B., 1978. The need to control skin temperature when using radiant heat in tests of analgesia. Exp. Neurol. 61, 471-478.
4. Galea, E., Regunathan, S., Eliopoulos, V., Feinstein, D.L., Reis, D.J., 1996. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 316, 247-249.
5. Gilad, G.M., Wollam, Y., Iaina, A., Rabey, J.M., Chernihovsky, T., Gilad, V.H., 1996. Metabolism of agmatine into urea but not into nitric oxide in rat brain. NeuroReport 7, 1730-1732.
6. Gonzalez, C., Regunathan, S., Reis, D.J., Estrada, C., 1996. Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br. J. Pharmacol. 119, 677-684.
7. Hartell, N.A., Headley, P.M., 1991. The effect of naloxone on spinal reflexes to electrical and mechanical stimuli in the anaesthetised, spinalised rat. J. Physiol. 442, 513-526.
8. Herrero, J.F., Headley, P.M., 1996. Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID. Br. J. Pharmacol. 118, 968-972.
9. Hole, K., Tjølsen, A., 1993. The tail-flick and formalin tests in rodents: Changes in skin temperature as a confounding factor. Pain 53, 247-254.
10. Jurkiewicz, N.H., Garcez do Carmo, L., Hirata, H., da Costa Santos, W., Jurkiewicz, A., 1996. Functional properties of agmatine in rat vas deferens. Eur. J. Pharmacol. 307, 299-304.
11. Kolesnikov, Y., Jain, S., Pasternak, G.W., 1996. Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296, 17-22.
12. Li, G., Regunathan, S., Barrow, C.J., Eshraghi, J., Cooper, R., Reis, D.J., 1994. Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263, 966-969.
13. Li, G., Regunathan, S., Reis, D.J., 1995. Agmatine is synthesised by a mitochondrial arginine decarboxylase in rat brain. Ann. N.Y. Acad. Sci. 763, 325-329.
14. 2 receptors. Eur. J. Pharmacol. 304, 221-229.
15. Loring, R.H., 1990. Agmatine acts as an antagonist of neuronal nicotinic receptors. Br. J. Pharmacol. 99, 207-211.
16. Meller, S.T., Gebhart, G.F., 1993. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52, 127-136.
17. Mendell, L.M., 1966. Physiological properties of of unmyelinated fibre projection to the spinal cord. Exp. Neurol. 16, 316-332.
18. Parsons, C.G., West, D.C., Headley, P.M., 1989. Spinal antinociceptive actions and naloxone reversibility of intravenous μ- and κ-opioids in spinalised rats: Potency mismatch with values reported for spinal administration. Br. J. Pharmacol. 98, 533-543.
19. Piletz, J.E., Chikkala, D.N., Ernsberger, P., 1995. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and Alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther. 272, 581-587.
20. 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: An electrophysiological study in rat. Neurosci. Lett. 219, 103-106.
21. 2-adrenoceptor binding sites. Br. J. Pharmacol. 115, 689-695.
22. 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 10-16.
23. Raasch, W., Regunathan, S., Li, G., Reis, D.J., 1995. Agmantine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 56, 2319-2330.
24. Regunathan, S., Feinstein, D.L., Raasch, W., Reis, D.J., 1995. Agmatine (decarboxylated arginine) is synthesised and stored in astrocytes. NeuroReport 6, 1897-1900.
25. Regunathan, S., Youngson, C., Raasch, W., Wang, H., Reis, D.J., 1996. Imidazoline receptors and agmatine in blood vessels: A novel system inhibiting vascular smooth muscle proliferation. J. Pharmacol. Exp. Ther. 276, 1272-1282.
26. Sastre, M., Regunathan, S., Galea, E., Reis, D.J., 1996. Agmatinase activity in rat brain: A metabolic pathway for the degradation of agmatine. J. Neurochem. 67, 1761-1765.
27. 2-adrenoceptors. Eur. J. Pharmacol. 215, 109-117.
28. Sun, M.-K., Regunathan, S., Reis, D.J., 1995. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anaesthetised rat. Clin. Exp. Hypertens. 17, 115-128.